A federal appeals court yesterday shot down a U.S. Tax Court decision in a longrunning transfer prcing dispute between Medtronic (NYSE:MDT) and the Internal Revenue Service. The IRS maintains that Fridley, Minn.-based Medtronic owes $1.4 billion in back taxes for transfer pricing arrangements among the company’s various units during the tax years 2005 and 2006. In transfer pricing, income is […]
Medtronic
Medtronic launches In.Pact Admiral drug-coated balloon in Japan
Medtech titan Medtronic (NYSE:MDT) said today that it launched its In.Pact Admiral drug-coated balloon in Japan. The company won approval and reimbursement for its device last year from the Japanese Ministry of Health, Labor and Welfare for the treatment of peripheral artery disease in the upper leg. Get the full story at our sister site, Drug Delivery Business News.
Report: New hack could put malware directly on Medtronic pacers, allow full control
Vulnerabilities within with Medtronic‘s (NYSE:MDT) pacemakers, its Carelink 2090 pacemaker programmer and associated infrastructure could allow an outside agent to plant malware on the pacers that would allow them to control all shocks delivered by the device, according to a new Wired report. The vulnerabilities were discovered by security firm Whitescope’s Billy Rios and QED […]
Medtronic launches Extravascular ICD pilot study
Medtronic (NYSE:MDT) said yesterday it launched a pilot study of its investigational Extravascular Implantable cardioverter defibrillator system, with the first patient implant already performed at New Zealand’s Christchurch Hospital. The Fridley, Minn.-based company’s EV ICD system uses leads placed outside of the heart and veins to provide both defibrillation and antitachycardia pacing therapy. The initial implantation […]
Report: ICS-CERT tags 2 Medtronic devices with cybersecurity vulnerabilities
The US Dept. of Homeland Security’s Industrial Control Systems Computer Emergency Response Team this week flagged two Medtronic (NYSE:MDT) devices for cybersecurity vulnerabilities that could allow attackers to obtain sensitive information, according to a HealthITSecurity report. The Fridley, Minn.-based medtech giant’s MyCareLink patient monitor and MiniMed Paradigm insulin pump and remote controller were specifically identified by the […]
Medtronic launches engagement program for diabetes patients
Medtronic (NYSE:MDT) said today that it launched its Inner Circle patient engagement program in the U.S. The medtech titan’s program, which is designed for people living with diabetes, uses gamification to motivate and encourage its users to practice behaviors that help them control their blood sugar levels. Get the full story at our sister site, Drug Delivery […]
The 10 most innovative medical devices of 2018
The nominees for the best medical technology of 2018 were recently announced for the 12th Annual Prix Galien USA Awards. The host of the awards, The Galien Foundation, awards the Prix Galien Award annually to examples of outstanding biomedical and technology product achievements that are designed to improve human condition. Before the candidates can qualify […]
Canada approves Medtronic’s Intellis spinal cord stimulator
Medtronic (NYSE:MDT) said today that Health Canada approved its Intellis spinal cord stimulator, touting it as the smallest such device on the market today. The device is designed to deliver mild electrical stimulation to nerves in the epidural space to treat chronic pain. The FDA approved Intellis in September 2017 and the system won CE […]
Hologic CFO McMahon jumps ship to Agilent | Personnel Moves – August 1, 2018
Hologic (NSDQ:HOLX) said yesterday that its CFO Bob McMahon is leaving to take up a CFO role at Agilent Technologies. The Marlborough, Mass.-based company said that its current chief accounting officer Karleen Oberton has been lifted to CFO, effective today. “Bob has made tremendous contributions to Hologic over the last four years, and we wish him […]
Medtronic wins FDA nod to deliver PAH therapy with implantable pump
Medtronic (NYSE:MDT) said today that it won FDA approval for its implantable drug-delivery system designed to administer United Therapeutics‘ (NSDQ:UTHR) pulmonary arterial hypertension drug, Remodulin. United Therapeutics is slated to take the lead on commercial promotion of the drug-device system, with support from Medtronic. Get the full story at our sister site, Drug Delivery Business News.
Medtronic agrees to $43m deal to settle shareholder Infuse lawsuit
Medtronic (NYSE:MDT) shareholders are seeking approval for a $43 million settlement deal to clear up claims related to its Infuse bone graft product, according to court documents. Shareholders in the case allege that Fridley, Minn.-based Medtronic engaged “in a scheme and course of conduct to defraud the investing public” in regards to clinical trials of the […]